1-n-(4-amino-3-fluoro-2-hydroxybutyryl)-kanamycins

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

536 137, 536 138, A61K 3170, C07H 1522

Patent

active

048732257

ABSTRACT:
As new compound are now provided ten compounds, namely 1-N-{(2R,3R)-4-amino-3-fluoro-2-hydroxybutyryl}kanamycin A; 1-N-{(2R,3R)-4-amino-3-fluoro-2-hydroxybutyryl}-2',3'-dideoxykanamycin A; 1-N-{(2R,3R)-4-amino-3-fluoro-2-hydroxybutyryl}-2',3'-dideoxy-2'-fluorokan amycin A; 1-N-{(2R,3R)-4-amino-3-fluoro-2-hydroxybutyryl}-5-deoxy-5-fluorokanamycin A; 1-N-{(2R,3R)-4-amino-3-fluoro-2-hydroxybutyryl}-kanamycin B; 1-N-{(2R,3R)-4-amino-3-fluoro-2-hydroxybutyryl}-3'-deoxykanamycin B; 1-N-{(2R,3R)-4-amino-3-fluoro-2-hydroxybutyryl}-3',4'-dideoxykanamycin B; 1-N-{(2R,3R) -4-amino-3-fluoro-2-hydroxybutyryl}-5-deoxy-5-fluorokanamycin B; 1-N-{(2R,3R)-4-amino-3-fluoro-2-hydroxybutyryl}-5,3'-dideoxy-5-fluorokanam ycin B; and 1-N{(2R,3R)-4-amino-3-fluoro-2-hydroxybutyryl}-5,3',4'-trideoxy-5-fluoroka namycin B, which are all useful as antibacterial agent in the therapeutic treatment of bacterial infections.

REFERENCES:
patent: 4170642 (1979-10-01), Umezawa et al.
patent: 4634688 (1987-01-01), Umezawa et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

1-n-(4-amino-3-fluoro-2-hydroxybutyryl)-kanamycins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 1-n-(4-amino-3-fluoro-2-hydroxybutyryl)-kanamycins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-n-(4-amino-3-fluoro-2-hydroxybutyryl)-kanamycins will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1957715

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.